Prognostic value of normal stress myocardial perfusion imaging in diabetic patients: A meta-analysis

Journal of Nuclear Cardiology

Volumn 21, Issue 5, 2014, Pages 893-902

  Acampa, Wanda ^a   Cantoni, Valeria ^b   Green, Roberta ^c   Maio, Francesca ^c   Daniele, Stefania ^a   Nappi, Carmela ^c   Gaudieri, Valeria ^c   Punzo, Giorgio ^a   Petretta, Mario ^c   Cuocolo, Alberto ^c  

^a CNR   (Italy)

^b IRCCS SDN   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

diabetes mellitus; Myocardial perfusion imaging; prognosis

Indexed keywords

COMORBIDITY; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS; EVIDENCE BASED MEDICINE; EXERCISE TEST; HUMAN; INCIDENCE; META ANALYSIS; MORTALITY; MYOCARDIAL PERFUSION IMAGING; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE;

COMORBIDITY; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS; EVIDENCE-BASED MEDICINE; EXERCISE TEST; HUMANS; INCIDENCE; MYOCARDIAL PERFUSION IMAGING; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 84929940046     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-014-9918-0     Document Type: Article

References (38)

1. Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleischmann KE. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: A meta-analysis. J Am Coll Cardiol 2007;49:227-37.
2. Acampa W, Petretta M, Cuocolo R, Daniele S, Cantoni V, Cuocolo A. Warranty period of normal stress myocardial perfusion imaging in diabetic patients: A propensity score analysis. J Nucl Cardiol 2014;21:50-6.
3. Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: What is the warranty period of a normal scan? J Am Coll Cardiol 2003;41:1329-40.
4. Hayden JA, Côté P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006;144:427-37.
5. Gargiulo P, Petretta M, Bruzzese D, Cuocolo A, Prastaro M, D’Amore C, et al. Myocardial perfusion scintigraphy and echocardiography for detecting coronary artery disease in hypertensive patients: A meta-analysis. Eur J Nucl Med Mol Imaging 2011;38:2040-9.
6. Gargiulo P, Dellegrottaglie S, Bruzzese D, Savarese G, Scala O, Ruggiero D, et al. The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: A meta-analysis. Circ Cardiovasc Imaging 2013;6:574-82.
7. Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323:42-6.
8. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
9. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
11. Cleophas TJ, Zwinderman AH. Meta-analysis. Circulation 2007;115:2870-5.
12. Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat 1950;21:607-11.
13. Miller JJ. The inverse of the Freeman-Tukey double arcsine transformation. Am Stat 1978;32:138.
14. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
15. Ghatak A, Padala S, Katten DM, Polk DM, Heller GV. Risk stratification among diabetic patients undergoing stress myocardial perfusion imaging. J Nucl Cardiol 2013;20:529-38.
16. Valensi P, Pariès J, Brulport-Cerisier V, Torremocha F, Sachs RN, Vanzetto G, et al. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: Influence of age in a French multicenter study. Diabetes Care 2005;28:2722-7.
17. Acampa W, Petretta M, Evangelista L, Daniele S, Xhoxhi E, De Rimini ML, et al. Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: A prospective, multicentre trial. Eur J Nucl Med Mol Imaging 2012;39:387-95.
18. Barmpouletos D, Stavens G, Ahlberg AW, Katten DM, O’Sullivan DM, Heller GV. Duration and type of therapy for diabetes: Impact on cardiac risk stratification with stress electrocardiographic-gated SPECT myocardial perfusion imaging. J Nucl Cardiol 2010;17:1041-9.
19. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32-40.
20. Hage FG, Wackers FJ, Bansal S, Chyun DA, Young LH, Inzucchi SE, et al. The heart rate response to adenosine: A simple predictor of adverse cardiac outcomes in asymptomatic patients with type 2 diabetes. Int J Cardiol 2013;167:2952-7.
21. Kasim M, Currie GM, Tjahjono M, Siswanto BB, Harimurti GM, Kiat H. Myocardial perfusion SPECT utility in predicting cardiovascular events among Indonesian diabetic patients. Open Cardiovasc Med J 2013;7:82-9.
22. Santos MT, Parker MW, Heller GV. Evaluating gender differences in prognosis following SPECT myocardial perfusion imaging among patients with diabetes and known or suspected coronary disease in the modern era. J Nucl Cardiol 2013;20:1021-9.
23. Matsuo S, Nakajima K, Yamasaki Y, Kashiwagi A, Nishimura T. Prognostic value of normal stress myocardial perfusion imaging and ventricular function in Japanese asymptomatic patients with type 2 diabetes: A study based on the J-ACCESS-2 database. Circ J 2010;74:1916-21.
24. Sultan A, Piot C, Mariano-Goulart D, Daures JP, Comte F, Renard E, et al. Myocardial perfusion imaging and cardiac events in a cohort of asymptomatic patients with diabetes living in southern France. Diabet Med 2006;23:410-8.
25. Pedone C, Schinkel AF, Elhendy A, van Domburg RT, Valkema R, Biagini E, et al. Incremental prognostic value of dobutamine-atropine stress 99mTc-tetrofosmin myocardial perfusion imaging for predicting outcome in diabetic patients with limited exercise capacity. Eur J Nucl Med Mol Imaging 2005;32:1057-63.
26. Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, DIAD Investigators, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: The DIAD study: A randomized controlled trial. JAMA 2009;301:1547-55.
27. Wiersma JJ, Verberne HJ, ten Holt WL, Radder IM, Dijksman LM, van Eck-Smit BL, et al. Prognostic value of myocardial perfusion scintigraphy in type 2 diabetic patients with mild, stable angina pectoris. J Nucl Cardiol 2009;16:524-32.
28. Hachamovitch R, Shaw L, Berman DS. Methodological considerations in the assessment of noninvasive testing using outcomes research: Pitfalls and limitations. Prog Cardiovasc Dis 2000;43:215-30.
29. Diamond GA, Kaul S, Shah PK. Screen testing cardiovascular prevention in asymptomatic diabetic patients. J Am Coll Cardiol 2007;49:1915-7.
30. Miller TD, Shaw LJ. Risk stratification in diabetic patients: A continuing challenge. J Nucl Cardiol. 2009;16:486-9.
31. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA, et al.; American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Nuclear Cardiology; American College of Radiology; American Heart Association; American Society of Echocardiology; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; Society of Nuclear Medicine. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol 2009;53:2201-29.
32. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al.; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010;122:e584-e636.
33. Perrone-Filardi P, Achenbach S, Möhlenkamp S, Reiner Z, Sambuceti G, Schuijf JD, et al. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: A position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology. Eur Heart J 2011;32:1986-93.
34. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013;36:S11-66.
35. Di Carli MF, Hachamovitch R. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes? J Am Coll Cardiol 2005;45:50-3.
36. Beller GA. Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type 2 diabetic patients: Is it appropriate and cost-effective? J Am Coll Cardiol 2007;49:1918-23.
37. Mulherin SA, Miller WC. Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Ann Intern Med 2002;137:598-602.
38. Schoenhagen P, Hachamovitch R. Evaluating the clinical impact of cardiovascular imaging: Is a risk-based stratification paradigm relevant? J Am Coll Cardiol 2013;61:185-6.